Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer’s Disease

Fibroblast growth factor 21 (FGF21) is a human metabolic hormone whose effects include modification of macronutrient preference and energy homeostasis. In animal models, FGF21 has been shown to have beneficial effects on cardiometabolic outcomes, Alzheimer’s disease risk and lifespan. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Susanna C., Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146158/
https://www.ncbi.nlm.nih.gov/pubmed/33946944
http://dx.doi.org/10.3390/nu13051504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146158/
https://www.ncbi.nlm.nih.gov/pubmed/33946944
http://dx.doi.org/10.3390/nu13051504

Ejemplares similares